Genprex Inc.

10/28/2024 | Press release | Distributed by Public on 10/27/2024 19:48

EROTC NCI AACR 2024 Poster – Efficacy of Quaratusugene Ozeplasmid (REQORSA) TUSC2 Gene Therapy in Glioblastoma